ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Insights into the Mechanistic Actions of Vitamin D3 in Colorectal Cancer Through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

[version 1; peer review: awaiting peer review]
PUBLISHED 30 Apr 2026
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS AWAITING PEER REVIEW

This article is included in the Bioinformatics gateway.

This article is included in the Cheminformatics gateway.

Abstract

Background

Colorectal cancer (CRC) ranks among the leading causes of cancer-related morbidity and mortality worldwide, yet effective preventive strategies targeting its complex molecular basis remain limited. Vitamin D3 has demonstrated pleiotropic anticancer properties in CRC; however, the precise systems-level mechanisms underlying its chemopreventive roles remain incompletely understood.

Methods

CRC-associated target genes were retrieved from DisGeNET and GeneCards, while vitamin D3 targets were predicted via SwissTargetPrediction and the SEA platform. Overlapping targets were identified using InteractiVenn and subjected to PPI network construction via STRING (v12.0) and visualized in Cytoscape. Hub genes were identified using the CytoHubba plugin, followed by GO and KEGG enrichment analyses using DAVID 2022. Molecular docking was performed using MOE 2022.02, and molecular dynamics simulations were conducted using YASARA Dynamics over 50 ns under physiological conditions, with structural stability assessed via RMSD analysis.

Results

A total of 110 overlapping targets were identified, with PPI analysis revealing ten hub genes — CYP19A1, AR, ESR1, MELK, CDK4, AURKA, CYP17A1, TOP2A, CDC45, and SRD5A1 — enriched in signal transduction, steroid metabolic processes, and the ErbB–MAPK signaling pathway. Molecular docking confirmed favorable binding affinities (−5.72 to −8.74 kcal/mol), with CYP19A1, SRD5A1, and CDC45 showing the strongest interactions. Molecular dynamics simulations confirmed stable binding conformations, particularly for AR and CDC45 (RMSD ~1.2–1.5 Å).

Conclusion

VD3 exerts potential chemopreventive effects against CRC through a multi-target mechanism involving cell cycle regulation, proliferative signaling, and steroid hormone metabolism, suggesting it modulates colorectal carcinogenesis by coordinating multiple signaling pathways.

Keywords

Vitamin D3, colorectal cancer, network pharmacology, molecular docking, molecular dynamics simulation, hub genes, MAPK signaling

Introduction

Colorectal cancer (CRC) remains a major global health burden and represents one of the leading causes of cancer-related morbidity and mortality worldwide. According to GLOBOCAN 2022, CRC ranks as the third most commonly diagnosed cancer, with over 1.9 million new cases, accounting for 9.6% of all incident cancers globally.1 In terms of mortality, CRC is the second leading cause of cancer-related death, responsible for approximately over 900 thousand deaths, or 9.3% of total cancer deaths worldwide.1 Despite substantial advances in screening programs, surgical techniques, and systemic therapies, disease recurrence and CRC-related mortality remain high, highlighting the urgent need for more effective preventive and adjunctive therapeutic strategies that address the complex molecular basis of colorectal carcinogenesis.2

Vitamin D deficiency has been consistently identified as a prevalent global health issue and is strongly associated with CRC incidence, progression, and mortality.3 Epidemiological and observational studies suggest that CRC is among the malignancies most closely linked to inadequate vitamin D status, with lower serum 25-hydroxyvitamin D [25(OH)D] levels correlating with increased cancer risk and poorer prognosis.4,5 Vitamin D3 (cholecalciferol), the biologically relevant form of vitamin D, is synthesized primarily through ultraviolet B exposure and undergoes hepatic and renal hydroxylation to form the active metabolite 1,25-dihydroxyvitamin D3 [1,25(OH)2D3].6 Beyond its classical role in calcium and phosphate homeostasis, vitamin D3 exhibits pleiotropic biological activities, including anti-proliferative, pro-apoptotic, anti-inflammatory, anti-angiogenic, and immunomodulatory effects, all of which are highly relevant to colorectal carcinogenesis.3,4,7

At the molecular level, vitamin D3 primarily acts through the vitamin D receptor (VDR) in intestinal epithelial cells, modulating genomic and non-genomic pathways that regulate cell cycle, apoptosis, immune responses, and tumor microenvironment dynamics.810 Despite this biological plausibility, the prognostic relevance of VDR-mediated immune mechanisms in CRC remains inconsistent and context-dependent. Therefore, integrative in silico approaches are required to clarify the systems-level mechanisms underlying the potential chemopreventive and therapeutic roles of vitamin D3 in CRC.

Methods

Network pharmacology analysis

Identification of colorectal cancer–associated target proteins

Colorectal cancer–associated target genes were systematically collected from two publicly available disease-related databases, namely DisGeNET (https://www.disgenet.org/) and GeneCards (https://www.genecards.org/), accessed on December 21, 2025.11,12 The search strategy employed the keywords “colorectal cancer” and “colorectal carcinoma” in both databases. All identified gene entries were compiled, after which duplicate records were removed. The curated gene lists from both sources were subsequently integrated to generate a consolidated dataset representing colorectal cancer–related target proteins.

Prediction of vitamin D3-related target proteins

The SMILES string of VD3 was retrieved from the PubChem Database, then submitted independently to SwissTargetPrediction (https://www.swisstargetprediction.ch/) and the Similarity Ensemble Approach (SEA) platform (https://sea.bkslab.org/), with both analyses restricted to Homo sapiens to ensure species-specific relevance. Protein targets predicted by the two platforms were combined into a single dataset, followed by the removal of duplicate entries.

Construction of the protein–protein interaction network

Potential therapeutic targets of VD3 in CRC were identified by intersecting peptide-associated proteins with breast cancer–related targets. The overlap between the two datasets was determined using the InteractiVenn web tool (http://www.interactivenn.net/). The intersecting genes were considered candidate targets involved in the pharmacological action of the peptide. These overlapping targets were subsequently imported into the STRING database (version 12.0; https://string-db.org/) to construct a protein–protein interaction (PPI) network. The analysis employed the “Multiple Proteins” option, restricted the organism to Homo sapiens, and applied a highest confidence score of 0.900. The generated interaction network was exported in TSV format and visualized using Cytoscape software (version 3.10.0). Within the PPI network, node size and color intensity reflected degree centrality, while edge thickness represented the combined interaction confidence score.13

Network topological properties and hub gene identification

Topological characteristics of the PPI network were quantitatively evaluated using the CytoHubba plugin implemented in Cytoscape. Hub genes were identified based on the degree centrality algorithm, and the ten nodes with the highest Maximal Clique Centrality (MCC) were selected as key hub targets.14 Overall centrality (OC) and clustering analyses were conducted in RStudio using the FactoMineR, factoextra, ggrepel, and ggplot2 packages.

Gene ontology and KEGG pathway enrichment analysis

To explore the biological processes and signaling pathways associated with the pharmacological activity of VD3 in CRC, enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID 2022; https://david.ncifcrf.gov/).15 The overlapping target genes derived from the PPI analysis were uploaded to the platform, with the species parameter set to Homo sapiens.

Gene Ontology (GO) enrichment analysis was conducted on the Molecular Function (MF), Cellular Component (CC), and Biological Process (BP) categories, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed to identify relevant signaling pathways. A significance threshold of p < 0.05 was applied to both analyses. Enriched GO terms and KEGG pathways were ranked based on ascending p-values, and the top ten entries were selected for visualization. Graphical representations, including bubble plots and bar charts, were generated using the SRplot online bioinformatics platform (https://www.bioinformatics.com.cn/), illustrating enrichment significance, gene counts, and pathway involvement related to VD3 in CRC pathophysiology.

Molecular docking analysis

Molecular docking was performed using MOE 2022.02 to evaluate the binding affinity of VD3 toward selected CRC–associated target proteins. Protein crystal structures were retrieved from the Protein Data Bank, followed by removal of co-crystallized ligands, water molecules, and heteroatoms, and energy minimization using the Amber10:EHT force field. Binding sites were predicted using the Site Finder Feature in MOE 2022.02. Docking was conducted using the triangle matcher algorithm with the London dG scoring function. Docked complexes were ranked based on binding free energy (kcal/mol) and refined through force-field minimization. Two-dimensional and three-dimensional visualizations were generated in MOE to characterize key residue interactions at the ligand–protein interface.16

Molecular dynamics simulation

Molecular dynamics simulations were performed employing YASARA Dynamics version 4.3.13. Protein–peptide complexes selected for analysis were loaded into the platform through the “Set Target” function and the “Macro & Movie” module available in the Options menu. Simulations were carried out under conditions approximating physiological homeostasis, including a temperature of 310 K, pressure of 1 atm, pH 7.4, and an ionic strength corresponding to 0.9% NaCl. The AMBER14 force field was utilized, and each system was solvated within a cubic periodic boundary box with a 10 Å margin from the protein surface. The duration of each simulation was defined as 50,000 ps (50 ns). Following completion of the trajectories, structural stability was assessed by calculating the root mean square deviation (RMSD) of Cα atoms using the MD_analysis macro. Graphical visualization and data plotting of the RMSD profiles were subsequently conducted using ORIGINPro 2024 (OriginLab, Massachusetts, United States).16

Results

Potential targets of vitamin D3 in colorectal cancer

A total of 20,115 CRC–related target proteins were identified, whereas 111 target proteins of VD3 were identified from databases. Cross-analysis of the two datasets revealed 110 overlapping targets, representing the shared molecular targets between VD3 and CRC ( Figure 1A).

d4e733e7-9330-4692-bd68-9b94e7433bd6_figure1.gif

Figure 1. (A) Venn diagram showing the overlap between CRC–associated targets and VD3–related targets, identifying 110 similar proteins, (B) Protein–protein interaction (PPI) network of the overlapping targets between vitamin D3 and CRC.

Protein–protein interaction (PPI) network construction

A total of 110 overlapping target proteins shared between VD3 and CRC were used to construct the PPI network. Interaction data were obtained from the STRING database (Homo sapiens, confidence score ≥ 0.900) and visualized using Cytoscape software (version 3.10.0). After removal of isolated nodes lacking defined interactions, the final PPI network comprised a densely connected interaction map, reflecting extensive functional associations among the VD3–CRC targets.

As illustrated in Figure 1B, nodes represent target proteins and edges denote predicted or experimentally supported protein–protein interactions. Topological analysis of the PPI network was performed using the cytoHubba plugin in Cytoscape. The MCC algorithm was applied to identify highly influential nodes within the network, and the top 10 hub genes were selected based on their MCC scores ( Figure 2). The identified hub targets included CDK4, AURKA, TOP2A, CDC45, MELK, SRD5A1, CYP17A1, CYP19A1, ESR1, and AR, all of which exhibited high connectivity and central positioning within the VD3–CRC interaction network. Detailed topological parameters of these hub genes, including MCC, Degree, Betweenness, and Closeness centralities, are summarized in Table 1. Among these targets, CDK4 and CYP19A1 displayed the highest degree and MCC values, indicating dominant regulatory roles within the network.

d4e733e7-9330-4692-bd68-9b94e7433bd6_figure2.gif

Figure 2. (A) Gene–function network of VD3–associated colorectal cancer targets showing key enriched biological processes, (B) Hub gene interaction network highlighting the top 10 core targets.

Table 1. Topological parameters of key hub proteins in the PPI network of VD3–associated CRC targets, including betweenness, closeness, degree, and overall centralities.

ProteinBetweennessClosenessDegree Overall
CYP19A13.0552172.0752452.41406721.96079
AR2.5381562.2191852.00687518.93933
ESR12.4513542.2684892.00687518.64846
MELK2.3610341.7182991.59968316.86813
CDK40.9821031.0006042.0068758.663143
AURKA0.4784390.9012111.1924915.125895
CYP17A10.3459051.2830051.1924914.589199
TOP2A−0.056610.1369491.1924910.977702
CDC45−0.16529−0.097621.5996830.366895
SRD5A1−0.566330.3416670.378107−2.44034

Gene ontology (GO) enrichment analysis results

In the BP category, the most significantly enriched terms included signal transduction, G protein–coupled receptor signaling pathway, lipid metabolic process, and positive regulation of cell population proliferation. Additional enriched BP terms comprised steroid metabolic process, regulation of gene expression, response to xenobiotic stimulus, inflammatory response, and positive regulation of cytosolic calcium ion concentration. These processes exhibited high gene counts and low p-values, indicating robust enrichment among the VD3–CRC overlapping targets ( Figure 3A).

d4e733e7-9330-4692-bd68-9b94e7433bd6_figure3.gif

Figure 3. (A) GO enrichment analysis of vitamin D3–associated colorectal cancer targets across biological process, cellular component, and molecular function categories, (B) Gene–GO term association network and enrichment overview illustrating gene ratios and statistical significance.

Analysis of the CC category revealed that target genes were predominantly associated with the membrane and plasma membrane, followed by the endoplasmic reticulum, receptor complex, and synapse-related structures, including postsynaptic membrane and neuron projection. Other enriched CC terms included the perinuclear region of cytoplasm, dendrite, and cell body fiber, reflecting diverse subcellular localizations of the identified targets ( Figure 3A).

Within the MF category, protein binding emerged as the most significantly enriched term, followed by metal ion binding, nucleotide binding, and ATP binding. Enrichment was also observed for G protein–coupled receptor activity, kinase activity, transferase activity, and specific subclasses such as protein serine/threonine kinase activity and protein serine kinase activity. These MF terms demonstrated notable gene ratios and statistical significance, indicating functional convergence among the VD3–CRC target proteins ( Figure 3A).

The integrated gene–term network visualization further illustrated the relationships between individual target genes and enriched GO categories, highlighting the distribution of targets across multiple biological processes, molecular functions, and cellular compartments. The size of nodes reflected gene counts, while color gradients corresponded to the level of statistical significance, providing an overview of functional enrichment patterns within the VD3–CRC target network ( Figure 3B).

KEGG pathway mapping results

KEGG pathway mapping was performed to visualize the distribution of VD3–related CRC target genes within canonical CRC signaling pathways ( Figure 4). The mapped targets were primarily localized to pathway branches related to cell proliferation and survival, with prominent involvement of AREG, EGFR, and MEK within the ErbB–MAPK signaling axis. These components were positioned at receptor-level and downstream kinase nodes, indicating coverage of multiple signaling tiers within CRC-related pathways.

d4e733e7-9330-4692-bd68-9b94e7433bd6_figure4.gif

Figure 4. KEGG pathway map of CRC, highlighting the involvement of VD3–associated targets in key signaling pathways related to proliferation, survival, and apoptosis.

In addition, VD3–CRC targets were mapped to interconnected signaling modules, including the MAPK cascade and downstream transcriptional regulators associated with proliferative responses. Overall, KEGG mapping highlights that VD3–CRC targets are integrated into key proliferation-related branches of colorectal carcinogenesis rather than being confined to isolated molecular nodes.

Molecular docking analysis

Molecular docking was performed to assess the interactions between VD3 and ten hub target proteins associated with CRC, including CDK4, AURKA, CYP17A1, TOP2A, CDC45, SRD5A1, MELK, CYP19A1, AR, and ESR1 ( Table 2). All VD3–protein complexes exhibited negative binding free energy values, ranging from −5.72 to −8.74 kcal/mol. The strongest binding affinities were observed for CYP19A1 (−8.74 kcal/mol), SRD5A1 (−8.23 kcal/mol), and CDC45 (−7.98 kcal/mol). RMSD values for all docked complexes were below 2.0 Å (0.96–1.94 Å), indicating stable and reliable docking conformations. Two-dimensional and three-dimensional visualizations were generated to illustrate the binding modes of VD3 within the target protein pockets ( Figure 5).

Table 2. Molecular docking results of VD3 with hub target proteins in CRC.

ProteinBinding Affinity (kcal/mol) RMSD (Å)
CDK4−5.721.35
AURKA−6.490.96
CYP17A1−6.231.84
TOP2A−7.211.60
CDC45−7.981.17
SRD5A1−8.071.94
MELK−6.841.42
CYP19A1−8.741.91
AR−6.351.42
ESR1−6.691.85
d4e733e7-9330-4692-bd68-9b94e7433bd6_figure5.gif

Figure 5. Representative 3D and 2D molecular docking interactions of vitamin D3 with selected hub target proteins.

Molecular dynamic simulations

Molecular dynamics simulations over 50 ns were performed to assess the stability of vitamin D complexes with CYP19A1, AR, AURKA, CDC45, CDK4, CYP17A1, ESR1, SRD5A1, TOP2A, and MELK ( Figure 6). Backbone RMSD analysis showed initial equilibration followed by stable trajectories for all complexes. AR and CDC45 exhibited the lowest RMSD values (~1.2–1.5 Å), indicating high structural stability, whereas TOP2A, MELK, and ESR1 displayed higher fluctuations, with RMSD values ranging between ~2 and 4.8 Å.

d4e733e7-9330-4692-bd68-9b94e7433bd6_figure6.gif

Figure 6. Molecular dynamics simulation profile (RMSD) of VD3 complexes with hub proteins over a 50 ns simulation period.

Discussion

Colorectal cancer remains a leading cause of cancer-related morbidity and mortality.1 Accumulating epidemiological evidence has suggested a protective association between VD3 and CRC, highlighting its potential role in cancer prevention.17 In the present study, an integrative network pharmacology approach was applied to elucidate the molecular mechanisms underlying the effects of VD3 in CRC. Cross-analysis identified a substantial number of overlapping targets between VD3 and CRC, indicating that VD3 may exert its biological activity through coordinated regulation of multiple disease-relevant proteins. Protein–protein interaction (PPI) network analysis further revealed several hub genes, including CDK4, AURKA, TOP2A, CDC45, MELK, CYP17A1, SRD5A1, CYP19A1, ESR1, and AR, which occupied central positions within the VD3–CRC interaction network. These hub proteins are primarily involved in cell cycle regulation, DNA replication, mitotic progression, and steroid hormone metabolism, suggesting that VD3 may influence CRC progression through both proliferative and endocrine-related mechanisms.5,9,18

Functional enrichment analysis supported these findings by demonstrating significant enrichment of biological processes related to signal transduction, regulation of cell population proliferation, lipid and steroid metabolic processes, and inflammatory responses. These processes are well recognized as key contributors to CRC initiation and progression. In addition, cellular component analysis revealed enrichment in membrane-associated structures and receptor complexes, suggesting that VD3-related targets may be involved in receptor-mediated signaling events. Molecular function enrichment further highlighted kinase activity, receptor activity, and protein binding, underscoring the involvement of VD3 in dynamic intracellular signaling networks rather than isolated molecular functions.

KEGG pathway mapping provided additional insight into the pathway-level involvement of VD3-associated targets in CRC. The identified targets were predominantly distributed within proliferation- and survival-related signaling pathways, particularly the ErbB–MAPK signaling axis, which involves AREG, EGFR, and MEK. The MAPK pathway is a central regulator of cell proliferation, differentiation, and survival, and has been extensively implicated in CRC development.19,20 The localization of VD3-related targets at both receptor-level components and downstream kinases suggests that VD3 may modulate CRC-related signaling cascades at multiple regulatory tiers, potentially contributing to growth inhibition and altered proliferative signaling.21

Molecular docking analysis validated the network-based findings by demonstrating stable interactions between VD3 and all identified hub proteins, and this structural evidence was further strengthened by molecular dynamics simulations using RMSD analysis. The consistently low backbone RMSD values observed throughout the simulation trajectories indicate that the initial docking conformations were retained over time, thereby supporting the structural reliability and dynamic stability of the VD3 protein complexes. Notably, complexes involving proteins central to steroid metabolism and DNA replication, including CYP19A1, SRD5A1, and CDC45, exhibited particularly stable RMSD profiles, reflecting limited conformational deviation and sustained ligand engagement. These findings reinforce the hypothesis that VD3 may directly modulate hormonal regulation and proliferative processes in CRC cells, and collectively provide time-resolved structural support that complements the systems-level insights derived from network pharmacology and enrichment analyses.2224

Taken together, the present findings suggest that VD3 acts as a multi-target regulatory molecule in CRC, influencing key biological processes including cell cycle control, proliferative signaling, hormone metabolism, and intracellular signal transduction. Rather than acting through a single pathway, VD3 appears to exert its effects through coordinated modulation of interconnected signaling networks central to colorectal carcinogenesis. Although the present study is based on computational analyses and requires further experimental validation, it provides a comprehensive mechanistic framework supporting the potential role of VD3 as a chemopreventive agent in CRC and offers a theoretical basis for future experimental and clinical investigations.

Conclusion

This study demonstrates that VD3 exerts potential chemopreventive effects against CRC through a multi-target and multi-pathway mechanism. Network pharmacology analysis identified key hub proteins involved in cell cycle regulation, proliferative signaling, and steroid hormone metabolism, which were further supported by functional enrichment and KEGG pathway mapping. Molecular docking results confirmed stable and favorable interactions between VD3 and these hub targets, providing structural validation for the network-based findings. Collectively, these results suggest that VD3 may modulate colorectal carcinogenesis by coordinating multiple signaling pathways rather than acting through a single molecular target.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 30 Apr 2026
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Rivai MI and Iqbal M. Insights into the Mechanistic Actions of Vitamin D3 in Colorectal Cancer Through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation [version 1; peer review: awaiting peer review]. F1000Research 2026, 15:651 (https://doi.org/10.12688/f1000research.178199.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status:
AWAITING PEER REVIEW
AWAITING PEER REVIEW
?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 30 Apr 2026
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.